Serum Peptide Profiling in Canine Cardiorenal Syndrome Using MALDI-TOF MS and Nano LC-MS/MS for Biomarker-Based Screening

Canine cardiorenal syndrome presents a significant clinical challenge, driven by the intricate interplay between heart and kidney diseases like myxomatous mitral valve disease (MMVD) and chronic kidney disease (CKD). Early detection and understanding of underlying mechanisms are critical for effective management.